WENAW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGW
Should you be buying Anew Medical stock or one of its competitors? The main competitors of Anew Medical include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.
Anew Medical (NASDAQ:WENAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership.
In the previous week, Anew Medical and Anew Medical both had 2 articles in the media. 180 Life Sciences' average media sentiment score of 1.44 beat Anew Medical's score of 0.44 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Anew Medical and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
180 Life Sciences beats Anew Medical on 1 of the 1 factors compared between the two stocks.
Get Anew Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for WENAW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
WENAW vs. The Competition
Anew Medical Competitors List
Related Companies and Tools